Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah N Mapelli

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
RNA Biology|August 15, 2017
Natural antisense transcripts drive a regulatory cascade controlling c-MYC transcriptionSara Napoli, Valentina Piccinelli, Sarah N Mapelli, et al.
Bioinformatics (Oxford, England)|December 12, 2018
Deciphering the complexity of human non-coding promoter-proximal transcriptomeSarah N Mapelli, Sara Napoli, Giuseppina Pisignano, et al.
Frontiers in Oncology|May 31, 2019
Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem CellsGianluca Civenni, Domenico Albino, Dheeraj Shinde, et al.
Cancers|October 17, 2020
Erratum: Mapelli, S.N., et al. A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors). <i>Cancers</i> 2020, <i>12</i>, 176Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
Cancers|January 16, 2020
A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors)Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
European Urology Oncology|July 7, 2019
Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC-8042 in ERG-positive Prostate CancerDheeraj Shinde, Domenico Albino, Marita Zoma, et al.
Frontiers in Immunology|October 3, 2022
A cytokine/PTX3 prognostic index as a predictor of mortality in sepsisSadaf Davoudian, Daniele Piovani, Antonio Desai, et al.
Nature Communications|July 7, 2021
EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancerMarita Zoma, Laura Curti, Dheeraj Shinde, et al.
Journal of Leukocyte Biology|August 4, 2021
Differential expression and regulation of MS4A family members in myeloid cells in physiological and pathological conditionsRita Silva-Gomes, Sarah N Mapelli, Marie-Astrid Boutet, et al.
Nature Communications|May 31, 2017
A promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancersGiuseppina Pisignano, Sara Napoli, Marco Magistri, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
RNA Biology|August 15, 2017
Natural antisense transcripts drive a regulatory cascade controlling c-MYC transcriptionSara Napoli, Valentina Piccinelli, Sarah N Mapelli, et al.
Bioinformatics (Oxford, England)|December 12, 2018
Deciphering the complexity of human non-coding promoter-proximal transcriptomeSarah N Mapelli, Sara Napoli, Giuseppina Pisignano, et al.
Frontiers in Oncology|May 31, 2019
Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem CellsGianluca Civenni, Domenico Albino, Dheeraj Shinde, et al.
Cancers|October 17, 2020
Erratum: Mapelli, S.N., et al. A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors). <i>Cancers</i> 2020, <i>12</i>, 176Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
Cancers|January 16, 2020
A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors)Sarah N Mapelli, Domenico Albino, Maurizia Mello-Grand, et al.
European Urology Oncology|July 7, 2019
Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC-8042 in ERG-positive Prostate CancerDheeraj Shinde, Domenico Albino, Marita Zoma, et al.
Frontiers in Immunology|October 3, 2022
A cytokine/PTX3 prognostic index as a predictor of mortality in sepsisSadaf Davoudian, Daniele Piovani, Antonio Desai, et al.
Nature Communications|July 7, 2021
EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancerMarita Zoma, Laura Curti, Dheeraj Shinde, et al.
Journal of Leukocyte Biology|August 4, 2021
Differential expression and regulation of MS4A family members in myeloid cells in physiological and pathological conditionsRita Silva-Gomes, Sarah N Mapelli, Marie-Astrid Boutet, et al.
Nature Communications|May 31, 2017
A promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancersGiuseppina Pisignano, Sara Napoli, Marco Magistri, et al.
Pageof 2